跳至主要内容
临床试验/NCT07344610
NCT07344610招募中不适用

Effects of Short-term Intensive Statin Therapy on Lipid Levels in Patients With Ischemic Stroke or Large Artery Atherosclerosis: A Prospective Observational Study

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2026年1月8日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
800
试验地点
1
主要终点
Absolute reduction in Low-Density Lipoprotein Cholesterol

研究概览

简要总结

Acute cerebral infarction (ACI), often linked to arterial stenosis, is a major cause of death and disability. Statins are cornerstone therapies for secondary prevention, effectively lowering LDL-C and stabilizing plaques. However, patient response to intensive statin therapy varies significantly. This prospective study aims to analyze the short-term lipid-lowering effects and influencing factors of such therapy in ACI patients with stenosis, to guide personalized treatment and improve outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years;
  • Diagnosis of ischemic stroke (within 14 days of onset) confirmed by cranial CT/MRI; or imaging-confirmed intracranial/extracranial atherosclerotic stenosis (stenosis rate ≥ 50%);
  • Intensive statin therapy (e.g., atorvastatin 40-80 mg/day or rosuvastatin 20 mg/day) initiated within 24 hours of admission, with a planned continuous application for at least one week;
  • Signed informed consent form.

排除标准

  • Use of statin therapy within 1 week prior to admission;
  • Receiving other lipid-lowering treatments;
  • Presence of other serious comorbidities (e.g., malignant tumors, end-stage heart failure) with an expected survival of <1 year;
  • Pregnant or lactating women;
  • Participation in other drug clinical trials within 3 months;
  • Other conditions deemed unsuitable by the investigator.

结局指标

主要结局

Absolute reduction in Low-Density Lipoprotein Cholesterol

时间窗: 7±1 days

次要结局

  • Absolute and relative reductions in other lipid parameters (Total Cholesterol, Triglyceride, High-Density Lipoprotein Cholesterol, Lipoprotein a)(7±1 days)
  • Changes in high-sensitivity C-reactive protein(7±1 days)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Sheng Chen

Director

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验